Arovella Therapeutics Limited (ASX:ALA)

Arovella Therapeutics Balance Sheet

Financials in millions AUD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Cash & Equivalents	20.88	12.71	5.18	6.07	6.72
Cash & Short-Term Investments	20.88	12.71	5.18	6.07	6.72
Cash Growth	64.20%	145.67%	-14.75%	-9.62%	587.20%
Accounts Receivable	-	-	0.01	0.04	0.01
Other Receivables	0.11	0.18	0	0	0.52
Receivables	0.11	0.18	0.01	0.04	0.53
Prepaid Expenses	0.11	0.21	0.03	0.06	0.09
Other Current Assets	0.07	0.05	0.2	0.42	-
Total Current Assets	21.17	13.15	5.42	6.59	7.34
Property, Plant & Equipment	0.43	0.13	0.05	0.37	0.43
Other Intangible Assets	-	-	-	0.13	0.13
Long-Term Deferred Charges	-	-	-	2.12	2.78
Total Assets	21.6	13.28	5.47	9.21	10.69
Accounts Payable	0.94	0.98	0.77	0.75	0.23
Accrued Expenses	0.13	0.08	0.3	0.28	0.2
Current Portion of Leases	-	-	-	0.07	0.08
Current Unearned Revenue	-	0.14	0.15	0.34	0.2
Other Current Liabilities	0.42	0.84	0.45	0.06	1
Total Current Liabilities	1.49	2.04	1.68	1.51	1.69
Long-Term Leases	-	-	-	0.08	0
Other Long-Term Liabilities	0.03	0.02	0.01	0.01	0.01
Total Liabilities	1.52	2.06	1.69	1.6	1.71
Common Stock	120.13	104.3	88.87	83.54	77
Retained Earnings	-102.84	-95.51	-87.06	-77.02	-68.47
Comprehensive Income & Other	2.79	2.44	1.96	1.11	0.45
Total Common Equity	20.08	11.23	3.78	7.62	8.98
Shareholders' Equity	20.08	11.23	3.78	7.62	8.98
Total Liabilities & Equity	21.6	13.28	5.47	9.21	10.69
Total Debt	-	-	-	0.14	0.08
Net Cash (Debt)	20.88	12.71	5.18	5.93	6.64
Net Cash Growth	64.20%	145.67%	-12.67%	-10.72%	644.16%
Net Cash Per Share	0.02	0.01	0.01	0.01	0.02
Filing Date Shares Outstanding	1,189	1,051	849.91	669.84	480.82
Total Common Shares Outstanding	1,189	1,051	849.91	669.84	480.82
Working Capital	19.68	11.11	3.74	5.08	5.65
Book Value Per Share	0.02	0.01	0.00	0.01	0.02
Tangible Book Value	20.08	11.23	3.78	7.48	8.85
Tangible Book Value Per Share	0.02	0.01	0.00	0.01	0.02
Machinery	0.71	0.34	0.25	1.07	1.19

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.